NON-SMALL LUNG CANCER
Clinical trials for NON-SMALL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SMALL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat lung cancer: SKB571 targets MET mutations
Disease control Recruiting nowThis study tests a new drug called SKB571 in 60 adults with advanced non-small cell lung cancer that has specific MET gene changes and has worsened after standard treatments. Participants receive SKB571 alone to see if it shrinks tumors and how safe it is. The goal is to control …
Matched conditions: NON-SMALL LUNG CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 17, 2026 06:25 UTC
-
New hope for lung cancer patients with a specific gene mutation
Disease control Recruiting nowThis study tests a drug called sotorasib in people with advanced non-small cell lung cancer that has a specific change in the KRAS gene (called G12C). Participants have not yet received any treatment for their advanced cancer. The goal is to see if sotorasib is safe and effective…
Matched conditions: NON-SMALL LUNG CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC